Abstract Scavenger receptors (ScRs) are a structurally unrelated family of receptors with the ability to bind modifi ed low density lipoprotein (LDL) as well as a broad range of polyanionic ligands. CD68, whose expression is restricted to mononuclear phagocytes, is a unique ScR family member, owing to its lysosome associated membrane protein (LAMP)-like domain and predominant endosomal distribution. Knockout (ko) mice were generated to directly evaluate the role murine CD68 may play in oxidized LDL (Ox-LDL) uptake. However, CD68
The characteristic pattern of expression on macrophages and a robust ex vivo affi nity for oxidized low-density lipoproteins (Ox-LDL) ( 10 ) led to the classifi cation of CD68 as a group D scavenger receptor ( 4, 11 ) . Consistent with its classifi cation as a LAMP-1 family member, CD68 was found to predominately localize to late endosomal and lysosomal compartments with a modest level of cell surface expression ( 12 ) . Its short cytoplasmic tail, ability to rapidly traffi c from cell surface to endosomes, and its intrinsic ability to bind Ox-LDL and phosphatidylserine, were often cited as evidence that CD68 served as a scavenger receptor ( 3, 10, 12, 13 ) .
Although initially characterized for their ability to direct lipid and apoptotic cell uptake, the ability of scavenger receptors (ScRs) to recognize polyanionic ligands has also afforded them an important role in the nonopsonic phagocytosis of numerous microbes ( 1, 4 ) . Consistent with this, a number of single and double murine ScR knockouts (ko) have validated their roles in these seemingly disparate infl ammatory processes ( 1, 4 ) . Although CD68 shares a number of these features, more recent studies have called into question its role in the recognition and uptake of Ox-LDL ( 14 ) . Rather, they raised the possibility that CD68 may regulate the response to ligands after internalization. To more carefully explore the potential role CD68 plays in the ability of macrophages to either take up or direct an innate response to Ox-LDL and microbial ligands, knockout mice were generated. Analysis of CD68 CD68 and its murine homolog, macrosialin, is a highly glycosylated, ‫ف‬ 95-110 kDa member of the lysosome-associated membrane protein (LAMP)-1 family, which is widely expressed on mononuclear phagocytes (1) (2) (3) . It was initially identifi ed as the antigen recognized by monoclonal antibodies directed against human and murine macrophage epitopes ( 2, 3 ) . Immunohistochemical studies revealed that CD68 expression was largely restricted to monocytes and tissue-specifi c macrophages, notably including those in the peritoneum, lungs, spleen, and liver, as well as Langerhans cells and microglia ( 1, 4 ) . Moreover, expression appeared to correlate with macrophage activation ( 5, 6 ) . Consistent with these observations, the CD68 promoter has been exploited successfully to direct the expression of transgenes toward the macrophage lineage in vivo (7) (8) (9) . dendritic cells (DC) were recovered ( ‫ف‬ 75% CD11c + ) and replated for an additional two or three days prior to analysis. Phagocytic activity was measured by incubating macrophages with either heat-killed FITC-labeled S. aureus as previously described ( 21 ) ; or LDL (Intracel Resources, Frederick, MD) that had been moderately oxidized with 40 M CuSO 4 as previously reported ( 22 ) . Lipid uptake was measured by fl ow cytometry of live cells by gating on DiI (1,1 ′ -dioetadeeyl-3,3,3 ′ ,3 ′ -tetramethylindocarboeyanine perchlorate; Sigma-Aldrich, St. Louis, MO) labeled Ox-LDL, or in fi xed PECs by staining with oil red O, as previously reported ( 22, 23 ) . PECs were also stained with antibodies specifi c for CD68 (1:100, 2 h; MAC1957, FA11; Serotec, Oxford, UK) and LAMP-1 (Southern Biotech, Birmingham, AL) after samples had been fi xed (4% paraformaldehyde, methanol; 20 min) and blocked (2% goat serum) as previously reported ( 24, 25 ) . Antibodies were detected with anti-rat IgG-FITC (1:100, 1 h; STAR69, Serotec) or anti-rat IgG-Cy3 (1:500, 1 h; Jackson ImmunoResearch, West Grove, PA) or anti-rat IgG-HRP (Vector Labs, Burlingame, CA) and visualized with a DAB substrate kit from Vectastain (Vector Labs) ( 23 ) . Images were captured with a Nikon Eclipse TE300 microscope on a Spot camera (Sterling Heights, MI) and analyzed with OpenLabs (Waltham, MA) software.
Microbicidal activity
The ability of macrophages to generate nitric oxide (NO) in response to treatment with lipopolysaccharide (LPS) (100 ng/ml; from E. coli serotype 055:B5; Sigma-Aldrich, St. Louis, MO) and/or IFN-␥ (50 U/ml; murine; PBL, Piscataway, NJ) was carried out as previously reported ( 24 ) . Growth of Legionella pneumophila , a facultative intracellular bacterium, was evaluated by infecting BMMs (0.5 × 10 6 per well in a 12-well plate, in triplicate) with 3,000 colony-forming units (CFU) of postlogarithmic growth bacteria, as recently reported ( 26 ) . The capacity of macrophages to promote viral growth was evaluated by infecting BMMs with vesicular stomatitis virus (VSV; Indiana strain) at multiple multiplicities of infections (MOI) and titering the supernatant for plaque-forming units (PFU) on Vero cells, as previously reported ( 24 ) .
Flow cytometry
Fluorescence activated cell sorting (FACS) analysis was carried out on cells harvested from euthanized mice. Broncho-alveolar lavage (BAL) fl uid was recovered in three sequential 1 ml (PBS) lung lavages, as reported ( 27, 28 ) . Bone marrow (BM) and peritoneal macrophages were prepared as described above. Additional leukocytes were harvested from femurs (BM cells) and spleen (splenocytes), or blood. Single-cell suspensions were RBC-depleted (Sigma), resuspended in RPMI 1640/10% FCS, and then counted and/or stained for FACS. Adherent cells (BMMs) were treated for 5 min with trypsin/EDTA (Sigma-Aldrich), whereas BMDCs were collected by gentle pipetting prior to staining for FACS. Cells were stained with anti-CD11b (M1/70), F4/80 (BM8), Gr-1 (RB6-8C5), CD8a (53-6.7), CD206 (48-2069) from eBioscience (San Diego, CA) or anti-CD11c (HL3), CD3e (145-2C11), CD4 (RM4-5), I-Ab (MHC-II; AF6-120.1), CD86 (GL1), NK1.1 (PK136) from BD Pharmingen (San Diego, CA) or anti-CD68 (MAC1957; FA11) and CD206 (MR5D3) from Serotec (Oxford, UK), after treatment with Fc-blocker (anti-CD16/CD32, 2.4G2; BD-Pharmingen). Cells were fi xed and stained with CD68 antibodies as per manufacturer (Serotec). Data were acquired on a FACS Calibur or FACS LSR-II (Beckton Dickinson, Franklin Lakes, NJ) and analyzed by FlowJo software (TreeStar, Ashland, OR).
Cytokine profi ling
Cultured macrophages or DCs were treated with LPS (100 or 1,000 ng/ml; Sigma), IFN-␥ (50 U/ml; murine; PBL, Piscataway, role in the uptake of either Ox-LDL, microbes, or an associated infl ammatory response. However, the enhanced capacity of these knockout cells to present antigen to CD4 + T-cells raises the possibility that CD68 may negatively regulate major histocompatibility complex class II (MHC-II) activity.
MATERIALS AND METHODS

Gene targeting
CD68 gene targeting vector was generated by PCR amplifi cation (Expanded Long Template PCR System; Roche, Indianapolis, IN) of a 1.6 kb short arm and 6.5 kb long arm from C57Bl6/J mice genomic DNA, as illustrated in Fig. 2 , with primers: 5 ′ T GC GGC CGC CCC TAT GCT GAA ACC CAA GTG TTC C 3 ′ and 5 ′ C TC TAG ACA TAT G AG AGA TGC TCA GAC CAG CTA GGC 3 ′ for the short arm and 5 ′ CTC GAG CGG CTC CCT GTG TGT CTG ATC TTG C 3 ′ and 5 ′ GCG GCC GC A GGA CAG GGG CTA CAC AGA AAC CC 3 ′ for the long arm (Not I, Xba I, Nde I, Xho I, and Not I endonuclease restriction sites are underlined and were included for cloning; New England Biolab, MA). A loxPfl anked neomycin cassette was amplifi ed from pMC1neo Poly A plasmid (Stratagene, San Diego, CA) with primers: 5 ′ CTC GAG ATA ACT TCG TAT AGC ATA CAT TAT ACG AAG TTA TGA ACA AAC GAC CCA ACA CCC GTG C 3 ′ and 5 ′ GTC GAC ATA ACT TCG TAT AAT GTA TGC TAT ACG AAG TTA TGC AGT GTG GTT TTG CAA GAG GAA GC 3 ′ (Xho I and Sal I enoduclease restriction sites are underlined) and cloned, inverted, downstream from an rtTA cassette ( 15 ) . This unit was then cloned immediately downstream and in frame with the CD68 initiation ATG located at the 3 ′ end of the short arm. The targeting construct was assembled in a vector provided by Dr. V. Lin that features a negative selectable diphtheria toxin (DT) gene ( 16 ) . The integrity of the targeting construct was confi rmed by sequencing prior to electroporation into 129 R1 ES cells ( 17 ) . Neomycin resistant clones were evaluated by Southern blotting with a probe localized to the 5 ′ end of the short arm (see Fig. 2 ). Properly targeted CD68 knockout ES cells (2 of 192 neomycin-positive clones) were introduced into blastocyts to generate chimeric mice, as previously reported ( 18 ) . Chimeric mice were either crossed with 129 mice or backcrossed seven generations to the C57Bl/6J background. Transmission of the knockout allele was determined by Southern blot and PCR. Columbia University review committees approved all relevant studies.
Cell culture
Resident peritoneal macrophages were harvested by lavage with 10 ml RPMI 1640 (Invitrogen-GIBCO, Grand Island, NY) supplemented with 10% FCS (Hyclone, Logan, UT) from freshly euthanized mice. Recovered cells were plated (1 × 10 6 cells/ml), and nonadherent cells were removed after 2 h by aspiration. Peritoneal-elicited cells (PEC; i.e., macrophages) were recovered by the same procedure four days after instillation of 1 ml of 4% thioglycollate (DIFCO; Voigt Global Dist., Inc, Lawrence, KS). Bone marrow-derived macrophages (BMMs) were prepared in RPMI 1640 supplemented with 10% FCS, penicillin/streptomycin (GIBCO), and 20% L-cell conditioned media, as previously reported ( 19 ) . Bone marrow-derived dendritic cells (BMDC) were prepared similarly, except that they were grown in RPMI 1640 supplemented with a 1/30 dilution of GM-CSF conditioned media (from J558 cells), 5% FCS, pen/strep, and ␤ -mercaptoethenol (GIBCO), as previously described ( 20 ) . Cells were fed gently with fresh media on days 3 and 5. On day 7, loosely adherent clustering To explore the potential role CD68 plays in ligand uptake, its gene was targeted for deletion by a recombination vector featuring two homology arms and a neomycin cassette (see Fig. 2 ). Chimeric mice with a targeted allele were then either crossed with 129 or C57Bl/6 mice and then NJ), interleukin (IL)-4 (10 ng/ml; Peprotech, Rocky Hill, NJ), zymosan (100 µg/ml; Sigma) or silicates (0.4 mg/ml; see below). Supernatants were collected after 24 h and evaluated by ELISA for tumor necrosis factor (TNF)-␣ and IL-6 production (eBioscience) or IL-1 ␤ production (Pierce, Rockford, IL). Quartz (Min-U-Sil 5) was a gift from US Silica (Berkeley Springs, WV) and featured >98% purity, an average size of 1.83 µm (range 1.70-1.89 µm), and no amorphous coating ( 29, 30 ) . Tridymite (99% purity, 0.5-1 µm, no amorphous coating) was a generous gift from B. Pernis ( 31, 32 ) . Silicates, which were baked at 250°C for 16 h prior to suspension in PBS, were sonicated prior to stimulation and negative for endotoxin contamination (Limulus assay; Cambrex Bio Science, Walkersville, MD).
T-cell analysis
An amount of 3 × 10 5 ovalbumin (OVA)-specifi c CD4 + T-cells (anti-CD4 MACS beads; Miltenyi Biotech, Auburn, CA) from OT-II TCR transgenic spleens were cultured for four days with 3 × 10 4 BMDCs, which had previously been loaded for 4 h with increasing concentrations of OVA (Worthington Biochemical Corporation, Lakewood, NJ) or OVA peptide 326-332 (New England Peptide, Inc., Gardner, MA). T-cell proliferation was measured by 3 H-thymidine incorporation (14 h, 37°C; Perkin Elmer Life Sciences, Shelton, CT), as previously reported ( 20 ) .
PCR
DNA or RNA was recovered from FACS-purifi ed leukocyte populations with Trizol (Invitrogen). RNA was reverse transcribed with SuperScript™ II (Invitrogen), as previously reported ( 19, 24 ) . DNA and cDNA were either PCR amplifi ed by standard or quantitative methods (ABI Prism 7700 with SYBR green master mix; Applied Biosystems, Foster City, CA). Gene expression was normalized to a ␤ -actin or 18S rRNA control. Ct values and standard curves were generated by plotting log of DNA concentration versus Ct values from 1:5 serial dilutions with SDS1.9.1 software (Applied Biosystems). Primers were annealed at 60 C and run 40 cycles. Primers sets included: Arginase-1 (forward) 5 ′ aga cca cag tct ggc agt tg, (reverse) 5 ′ cca ccc aaa tga cac ata gg; 18S (forward) 5 ′ tca aga acg aaa gtc gga gg 3 ′ , (reverse) 5 ′ gga cat cta agg gca tca ca 3 ′ ; eif4a1 (forward) 5 ′ gga agg cgt cat cga gag taa ctg, (reverse) 5 ′ ccc aat gca ggc atg aca aag agg; mupd.1 (forward) 5 ′ gcg ctg ttc ctg aca ctc cag acc, (reverse) 5 ′ cca gta gaa gag gac ctg ggc agc.
RESULTS
Characterization and deletion of CD68
Although predominately restricted to endosomes, CD68 expression has been largely associated with myeloid cells from the macrophage lineage ( 1 ). Consistent with previous reports, CD68 staining was strongest after membrane permeablization, and it was largely localized to LAMP1-positive vesicles (supplementary Fig. I ) ( 1 ) . When primary murine myeloid cells were evaluated, strong CD68 expression was observed in several macrophage lineages, including alveolar, splenic, BM, and peritoneal macrophages, as well as BM culture-derived macrophages (see Fig. 1 ) ( 1,  33 ) . Likewise, robust CD68 expression was observed in several DC populations, including pulmonary-and splenic-CD8 ␣ + DCs and BM culture-derived DCs, but not in CD8 ␣ − DCs ( Fig. 1 ) . As anticipated, CD68 was not detected on B220 + or CD3 + lymphocytes (not shown). 
interbred to homozygosity. Progeny CD68 knockout (CD68 Ϫ / Ϫ ) mice developed with normal Mendelian genetics in both backgrounds (e.g., Fig. 2B ; data not shown); they exhibited no obvious phenotypes, including no evidence of organomegally and no signifi cant perturbations of defi ned leukocyte populations in either the blood or spleen ( Tables 1 and 2 ; supplementary Fig. II ). Western blotting, immunohistochemical studies, and FACS analysis confi rmed an absence of CD68 expression in macrophages from CD68 knockout mice ( Fig. 2C-E ) . CD68 +/ Ϫ (i.e., heterozygous) mice exhibited a corresponding partial decrease in CD68 expression ( Fig. 2C ) . Given the relatively high density of genes at the CD68 locus, it was important to confi rm that the expression of both eif4a1 and mpdu.1 (upstream and downstream fl anking genes; see Fig. 2 ) was not affected by the introduction of a neomycin cassette into the CD68 locus (supplementary Fig. III ). In summary, these studies revealed that homozygous deletion of the CD68 gene was not associated with any signifi cant developmental or homeostatic defects.
CD68
؊ / ؊ macrophages exhibit normal scavenger receptor activity Shortly after its initial characterization ( 3, 34 ) , CD68 was identifi ed as a 94-97 kDa receptor for Ox-LDL, adding it to the growing family of scavenger receptors ( 1, 4 Ox-LDL as well as other ligands into the endosomal compartment ( 12 ) . Subsequent RNAi knockdown studies, however, failed to confi rm a signifi cant role for CD68 in Ox-LDL uptake ( 14 ) . To more rigorously explore the capacity of CD68 to serve as a scavenger receptor, primary peritoneal macrophages were harvested from knockout mice and incubated with increasing concentrations of Ox-LDL. Both wild-type and knockout macrophages took up Ox-LDL in a dose-dependent manner ( Fig. 3A , B ; supplementary Fig. IV) . Intriguingly, CD68 Ϫ / Ϫ macrophages even exhibited a trend toward enhanced Ox-LDL uptake at lower doses. Next, the more general phagocytic activity of CD68 knockout macrophages was evaluated by incubating cells with fl uorescently-labeled, heat-killed Staphylococcus aureus . Again, CD68 Ϫ / Ϫ macrophages exhibited a dose-dependent uptake of bacteria that paralleled the pattern observed in wild-type macrophages ( Fig. 3B , top panels) . Moreover, CD68 Ϫ / Ϫ macrophages exhibited no signifi cant differences in either the binding (i.e., 4°C) or uptake (i.e., 37°C) of opsonized, labeled, heat-killed S. aureus ( Fig. 3B , bottom panels), suggesting that CD68 does not play an important role in either Ox-LDL or bacteria uptake by macrophages.
Innate immune response in CD68 ؊ / ؊ macrophages
Since CD68 is predominately localized to the endosomal compartment, its capacity to contribute to the innate intracellular response to microbial pathogens was explored. First, the capacity to generate NO, an important antibacterial effector, was evaluated ( 35 ) . As shown in Fig. 4A , both wild-type (wt) and CD68 Ϫ / Ϫ macrophages produced equivalent quantities of NO in response to stimulation with IFN-␥ and LPS. Next, the capacity of CD68 to affect the innate response to microbial infection was evaluated. Consistent with previous studies on the innate response, when murine macrophages were infected with L. pneumophila , they replicated modestly over a four-day period ( Fig. 4B ) Splenocytes from three-month-old matched wild-type (wt), heterozygous (het), and CD68 Ϫ / Ϫ (ko) mice (as in Table 1 ) were stained for B220 (B lymphocytes), CD3 (T lymphocytes), CD11b (macrophages), and CD11c (dendritic cells) and analyzed by FACS. Mean and standard deviation of the percentage of positive cells are shown. phenotype, which is characterized by CD206, arginase 1, and IL-10 expression (supplementary Fig. V) ( 39 ) .
Next, we examined the ability of CD68 Ϫ / Ϫ macrophages to respond to silica crystals (e.g., quartz), which have recently been shown to robustly stimulate IL-1 ␤ secretion through activation of the infl ammasome ( 30, 32, 38 ) . Wild-type and CD68 Ϫ / Ϫ peritoneal macrophages were stimulated with two forms of highly purifi ed, endotoxinfree crystalline silica, tridymite, and quartz. Again, the response of CD68 Ϫ / Ϫ macrophages was equivalent to wt macrophages ( Fig. 5B ) . Additional studies confi rmed that these responses were sensitive to cytochalasin D (data not shown), suggesting these crystals must enter the cell to be sensed ( 30, 38 ) . In summary, these studies revealed that CD68 does not signifi cantly contribute to the innate response to a divergent set of infl ammatory stimulants.
Adaptive immunity in CD68 ؊ / ؊ mononuclear phagocytes
Having excluded an important role for CD68 in either the uptake or infl ammatory responses associated with innate immunity, the possibility that CD68 might play a role in adaptive immunity was explored. Because of their potent capacity to present antigens, these studies focused on at both low MOIs, which feature a more robust innate response, and at the higher MOIs favoring more robust viral growth ( Fig. 4C ) .
The infl ammatory response of CD68
؊ / ؊ mononuclear phagocytes In addition to their phagocytic capacity, mononuclear phagocytes feature a number of innate immune receptors that detect pathogen-associated molecular patterns (PAMP; e.g., LPS and zymosan) ( 37 ) and danger-associated molecular patterns (DAMP; e.g., silica) ( 30, 38 ) , which direct the secretion of potent infl ammatory cytokines (e.g., TNF-␣ , IL-1 ␤ , and IL-6). To examine whether CD68 might contribute to this response, CD68
Ϫ / Ϫ macrophages and DCs were stimulated with a few PAMPs and DAMPs. No differences were observed in the capacity of either LPS or Zymosan to stimulate TNF-␣ or IL-6 production in either wild-type or CD68
Ϫ / Ϫ macrophages or DCs ( Fig. 5A ) . Moreover, the robust infl ammatory response of CD68 Ϫ / Ϫ macrophages to LPS ( Fig. 5A ) and IFN-␥ (data not shown) indicated that CD68 does not play a signifi cant role in the response of classically activated M1 macrophages. Likewise, no differences were observed in the ability of CD68 Ϫ / Ϫ macrophages to be polarized to the M2 noninfl ammatory DCs. First, PAMP-dependent upregulation of MHC-II and coreceptors was examined. These studies highlighted a modest increase in basal MHC-II, but not CD86, surface expression in CD68 Ϫ / Ϫ BMDCs ( Fig. 6A ) . However, the robust, LPS-dependent induction of MHC-II was essentially equivalent in wt and CD68 Ϫ / Ϫ DCs. CD86 upregulation was modestly enhanced in CD68 Ϫ / Ϫ DCs.
Next, DCs were loaded with increasing doses of OVA to evaluate their ability to present antigen to OVA-MHC-II-specifi c OT-II T-cells. At lower, nonsaturating concentrations of OVA, wt and CD68
Ϫ / Ϫ DCs were equivalent in their capacity to stimulate proliferation of naïve OT-II Tcells ( Fig. 6B ). Yet at higher, but not the highest, concentration of OVA (i.e., 0.05 and 0.1 mg/ml; Fig. 6B ) CD68 Ϫ / Ϫ DCs exhibited increased ability to stimulate Tcell proliferation. Similarly, CD68 Ϫ / Ϫ DCs loaded with a specifi c OT-II-activating OVA peptide stimulated more robust T-cell proliferation at higher doses ( Fig. 6B ). These observations raised the possibility that CD68 may negatively regulate the capacity of DCs to present antigen to naïve T-cells, especially under conditions of high antigen load.
DISCUSSION
CD68 is a member of the ScR family that has been widely exploited as a macrophage marker (reviewed in Refs. 1, 4, and 11 ). However, consistent with its conserved "extracellular" LAMP domain, CD68 predominately localizes to LAMP-1-positive intracellular vesicles. Expression is upregulated in response to various infl ammatory stimuli, including oxidized LDL. Yet, despite robust binding activity, CD68's role in either the endocytosis or processing of oxidized LDL remains controversial ( 3, 10, (12) (13) (14) . To more rigorously evaluate the role of this conserved member of the LAMP-1 family in infl ammatory responses, CD68 knockout mice were generated. Initial characterization of tissues from CD68 Ϫ / Ϫ mice underscored a loss of expression in both macrophage and DC populations that normally express CD68. Moreover, this was not associated with a perturbation in either the number or distribution of any leukocyte populations recovered from the blood, spleen, peritoneum, lung, or lymph nodes. With a robust affi nity for Ox-LDL and phosphatidylserine, initial studies had implicated CD68 in modifi ed lipid uptake ( 12, 40 ) . However, subsequent ectopic overexpression and partial knockdown studies failed to support an important role for CD68 in Ox-LDL uptake ( 14 ) . Consistent with these observations, CD68
Ϫ / Ϫ peritoneal macrophages ( Fig. 3 ; supplementary Fig. IV ) and BMMs (data not shown) failed to exhibit any defect in Ox-LDL uptake. Rather, several experiments revealed a trend toward enhanced lipid uptake in CD68 Ϫ / Ϫ macrophages.
Having excluded an important role in Ox-LDL uptake, it was important to determine whether CD68 might direct the uptake of bacteria, a property associated with other ScRs. However, CD68
Ϫ / Ϫ macrophages were fully able to bind and phagocytose both nonopsonized and opsonized S. aureus ( Fig. 3B ) . Likewise, CD68
Ϫ / Ϫ macrophages (see Fig. 4 ) and mice (data not shown) exhibited a normal innate response to infection with bacterial pathogens (e.g., S. aureus and L. monocytogenes; data not shown) and VSV. These observations are consistent with the possibility that CD68 may play a redundant role in phagosome-lysosome fusion, as has recently been reported in LAMP-1/LAMP-2 double-knockout murine embryonic fi broblasts (MEFS) ( 41 ) . This potentially redundant role will be explored in future studies. Next, we considered the possibility that CD68 might regulate other aspects of the immune response. First, the ability of a few signature PAMPs and DAMPs to stimulate an infl ammatory response in either macrophages or DCs was evaluated. Again, the loss of CD68 was not associated with any defect in cytokine production ( Fig. 5 ) , but there was a trend toward modestly enhanced DC activation (i.e., cell surface CD86 and MHC-II expression) in CD68 Ϫ / Ϫ mononuclear phagocytes. Consistent with a potential role in regulating the ability of these cells to present antigens, OVA-loaded CD68
Ϫ / Ϫ DCs were found to be more effective in stimulating the proliferation of OVA-MHC-II-specifi c, OT-II T-cells, especially at higher doses of this antigen ( Fig. 6 ). The equally enhanced capacity of CD68 Ϫ / Ϫ DCs to present ovalbumin peptide to OT-II T-cells suggests that CD68 is not likely to regulate antigen processing but, rather, MHC-II loading or transport or both to the cell surface. Intriguingly, LAMP-1 and LAMP-2 may regulate Rab7-dependent phago-lysosomal interactions and traffi cking ( 41 ) . Moreover, LAMP-2 has been implicated in the "retrograde" movement of MHC-II molecules from a late-endosome/lysosome-like, multivesicular body, where they are stored and loaded with antigen into CD68-positive tubular structures, from which antigen-loaded MHC-II vesicles appear to bud on their way to the cell surface ( 42, 43 ) . Consistent with the possibility that CD68 may negatively regulate this process, basal MHC-II surface expression was enhanced in CD68 Ϫ / Ϫ DCs. However, this enhanced capacity to present antigens in vitro was not associated with a proclivity toward autoimmunity (aged CD68 Ϫ / Ϫ mice remained healthy) or an overly exuberant innate response to bacterial infection. Future studies will need to more rigorously evaluate the potential role CD68 plays in regulating the complicated movement of MHC-II molecules from multivesicular bodies, where they are antigen-loaded, to the cell surface, where they present antigen. This investigation will include exploring whether loss of CD68 is associated with changes in either the quantity or quality of adaptive T-cell-dependent responses, as well as humoral immunity during controlled immune challenges.
